Royal Bank of Canada Purchases 4,274 Shares of Hawkins, Inc. $HWKN

Royal Bank of Canada raised its position in Hawkins, Inc. (NASDAQ:HWKN) by 3.7% during the first quarter, Holdings Channel reports. The institutional investor owned 119,368 shares of the specialty chemicals company’s stock after buying an additional 4,274 shares during the quarter. Royal Bank of Canada’s holdings in Hawkins were worth $18,335,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Values First Advisors Inc. lifted its stake in shares of Hawkins by 0.8% during the first quarter. Values First Advisors Inc. now owns 9,855 shares of the specialty chemicals company’s stock valued at $1,514,000 after acquiring an additional 79 shares during the period. Truist Financial Corp boosted its holdings in Hawkins by 4.7% in the fourth quarter. Truist Financial Corp now owns 1,852 shares of the specialty chemicals company’s stock valued at $263,000 after acquiring an additional 83 shares during the last quarter. Farther Finance Advisors LLC increased its position in Hawkins by 0.6% in the fourth quarter. Farther Finance Advisors LLC now owns 15,090 shares of the specialty chemicals company’s stock worth $2,144,000 after purchasing an additional 88 shares during the period. ProShare Advisors LLC increased its position in Hawkins by 3.0% in the fourth quarter. ProShare Advisors LLC now owns 3,815 shares of the specialty chemicals company’s stock worth $542,000 after purchasing an additional 112 shares during the period. Finally, Quantinno Capital Management LP raised its holdings in Hawkins by 0.9% during the 2nd quarter. Quantinno Capital Management LP now owns 13,618 shares of the specialty chemicals company’s stock worth $1,935,000 after purchasing an additional 124 shares during the last quarter. 69.71% of the stock is owned by institutional investors and hedge funds.

Hawkins Trading Down 3.9%

NASDAQ HWKN opened at $130.03 on Friday. The stock has a 50-day simple moving average of $146.58 and a 200 day simple moving average of $149.32. The company has a market capitalization of $2.72 billion, a PE ratio of 33.69, a P/E/G ratio of 2.79 and a beta of 0.79. The company has a current ratio of 2.27, a quick ratio of 1.54 and a debt-to-equity ratio of 0.45. Hawkins, Inc. has a 12 month low of $117.98 and a 12 month high of $186.15.

Hawkins (NASDAQ:HWKN) last released its earnings results on Wednesday, July 29th. The specialty chemicals company reported $1.35 earnings per share for the quarter, missing the consensus estimate of $1.39 by ($0.04). The company had revenue of $315.68 million during the quarter, compared to analyst estimates of $313.42 million. Hawkins had a net margin of 7.29% and a return on equity of 15.42%. Research analysts forecast that Hawkins, Inc. will post 4.04 EPS for the current year.

Hawkins Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, August 28th. Investors of record on Friday, August 14th will be given a $0.19 dividend. This represents a $0.76 dividend on an annualized basis and a dividend yield of 0.6%. The ex-dividend date is Friday, August 14th. Hawkins’s dividend payout ratio (DPR) is currently 19.69%.

Analyst Upgrades and Downgrades

A number of research analysts have issued reports on HWKN shares. Barclays set a $142.00 target price on shares of Hawkins and gave the company an “equal weight” rating in a research report on Friday, July 31st. Zacks Research downgraded shares of Hawkins from a “hold” rating to a “strong sell” rating in a research note on Tuesday. Weiss Ratings lowered shares of Hawkins from a “buy (b-)” rating to a “hold (c+)” rating in a report on Tuesday, July 14th. Finally, BWS Financial reaffirmed a “buy” rating and issued a $200.00 price objective on shares of Hawkins in a research note on Monday. One research analyst has rated the stock with a Buy rating, two have given a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, the company presently has an average rating of “Hold” and a consensus price target of $171.00.

More Hawkins News

Here are the key news stories impacting Hawkins this week:

• Positive Sentiment: Sidoti made modest upward revisions to its EPS forecasts for Q2 2027, Q1 2028 and Q2 2028, indicating some expected strength in those periods. Sidoti’s FY2028 forecast remains a substantial $5.00 per share despite recent quarterly reductions. Hawkins analyst estimates
• Neutral Sentiment: Sidoti’s estimates imply FY2027 EPS of $4.20 and FY2028 EPS of $5.00, providing investors with a framework for longer-term earnings growth. However, these figures are analyst projections and remain subject to changes in chemical demand, pricing and operating costs. Hawkins earnings estimates
• Negative Sentiment: Zacks Research downgraded Hawkins from “hold” to “strong sell,” a notably bearish change that likely weighed on investor confidence. Zacks Research report
• Negative Sentiment: Sidoti cut its FY2027 EPS forecast to $4.20 from $4.45 and its FY2028 forecast to $5.00 from $5.35. It also reduced estimates for Q3 2027, Q4 2027, Q3 2028 and Q4 2028, signaling weaker expected earnings momentum in several periods. Sidoti Hawkins estimates
• Negative Sentiment: The company’s latest quarterly results also showed an EPS miss, with reported earnings of $1.35 per share versus the $1.39 consensus estimate. Against this backdrop, downward revisions and the “strong sell” rating reinforce concerns that Hawkins’ current valuation may not fully reflect near-term earnings risks.

Hawkins Company Profile

Hawkins, Inc (NASDAQ: HWKN) is a specialty chemical company that produces and distributes water-treatment and industrial chemicals across North America. Founded in 1938 and headquartered in Roseville, Minnesota, the company has built a network of manufacturing facilities and distribution centers that serve municipal, industrial and commercial customers. As a publicly traded entity, Hawkins leverages its long-standing presence in the chemical distribution industry to provide tailored solutions for complex water-treatment challenges and specialty chemical needs.

Hawkins’ product portfolio encompasses a wide range of chemicals, including sodium hypochlorite, sodium hydroxide, hydrogen peroxide, chlorine, acids and specialty blends.